Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02843165
Title Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation in Advanced Metastatic Disease
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Diego
Indications

Advanced Solid Tumor

Therapies

unspecified PD-L1 antibody

unspecified CTLA4 antibody

unspecified PD-1 antibody

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.